Dean Tuck – Managing Director – Dreadnought Resources (ASX:DRE) is a highly active West Australian mineral explorer focused on finding the metals needed now and in the future.
Copyright 2024 – Finance News Network
25 Nov 2019 - Lepidico (ASX:LPD) Managing Director, Joe Walsh provides an update on drill results from its recently acquired Rubicon and Helikon deposits in Namibia, L-Max Pilot Plant trial results and outlook.
07 Jun 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's phase 1 trial results for its chlorotoxin CAR T (CLTX CAR T) cell therapy targeting glioblastoma.
15 Jan 2021 - Famed investor, author and market analyst Jim Rogers discusses the impact of the COVID-19 vaccine rollout, Chinese wine stocks, the bond bubble, why he is bullish on commodities, allegations of currency manipulation and how Aussie investors can get ahead.
21 Aug 2023 - Cauldron Energy Limited (ASX:CXU) CEO Jonathan Fisher discusses the company's progress with its portfolio of assets, including the Melrose nickel-copper project in WA.
21 May 2021 - Hazer Group Limited (ASX:HZR) CEO & Managing Director Geoff Ward provides an update on the company's Commercial Development Project at the Woodman Point Wastewater Treatment Plant south of Perth, a 100 tonne per annum hydrogen production facility using waste gas produced through the water treatment facilities.
26 Sep 2019 - First Graphene Limited (ASX:FGR) Executive Director and CFO, Peter Young talks about the company's worldwide licensing agreement with the University of Manchester for its technology used in supercapacitors.
25 Sep 2023 - Wally Graham of Resources Roadhouse at the New World Metals Conference, speaking with Juan Pablo Vargas de la Vega, Managing Director of Galan Lithium (ASX:GLN).
16 June 2020 - Social Tree Global co-founders, Max Hannah and James Saward-Anderson share their top 5 hacks for harnessing the power of social media in financial services.
31 Oct 2023 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses progress of the company's drug candidates, highlighting promising data from the 2023 ESMO Congress.